Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea

View source ↗

Summary

An observational study evaluating gut microbiota in breast cancer patients treated with abemaciclib, comparing those with diarrhea to those without diarrhea. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Breast Neoplasms, Hormone Receptor-Positive Breast Cancer | Status: RECRUITING